RxDoctor Payments Data

Mark Catron, PA

Medical · Berea, KYNPI 1811933989

Payments from drug & device makers

$242in general payments, 2019–2025

Across 16 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Xeris Pharmaceuticals, Inc.$70
  • GSK$36
  • Exact Sciences$32
  • Johnson & Johnson$27
  • Lilly USA, LLC$20
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$18
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$242 in reported general payments places this provider in the 25th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,824
Medicare patients
21
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KeveyisDichlorphenamide11$259,660
OzempicSemaglutide75$98,051
JardianceEmpagliflozin45$52,496
EliquisApixaban39$38,965
JanuviaSitagliptin Phosphate29$35,501
XareltoRivaroxaban31$27,601
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$26,401
BrilintaTicagrelor13$14,897
EntrestoSacubitril/Valsartan11$11,624
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,933
SymbicortBudesonide/Formoterol Fumarate19$6,913
Spiriva RespimatTiotropium Bromide13$6,449
Ventolin HfaAlbuterol Sulfate58$4,269
Albuterol Sulfate HfaAlbuterol Sulfate135$3,643
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Xeris Pharmaceuticals, Inc.Keveyis$70$259,66011 claims
AstraZenecaBrilinta, Breztri Aerosphere, Symbicort$15$30,74346 claims
Johnson & JohnsonXarelto$27$27,60131 claims
GSKTrelegy Ellipta$36$26,40121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 222 medical providers in Kentucky.

Other medical in Berea

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →